Literature DB >> 31182412

Subsidence of Hydroxyapatite-Coated Femoral Stem in Dorr Type C Proximal Femoral Morphology.

Piti Rattanaprichavej1, Artit Laoruengthana1, Thanainit Chotanaphuti2, Saradej Khuangsirikul2, Chanadol Phreethanutt2, Krit Pongpirul3.   

Abstract

BACKGROUND: Good bone quality and proper proximal femoral morphology are thought to be necessary for tapered design, cementless femoral stems to resist subsidence. Using tapered, cementless stem for patients with stovepipe morphology or Dorr type C is controversial. The purpose of this study is to analyze (1) subsidence of the fully hydroxyapatite (HA)-coated, tapered, cementless stem in different morphology according to Dorr classification, (2) subsidence of the stem related to radiographic canal-fill ratio.
METHODS: The digitized radiographs of 311 consecutive cementless primary total hip arthroplasty with fully HA-coated, tapered stem were retrospectively reviewed. Subsidence and the canal-fill ratio at 4 locations were evaluated postoperatively after a minimum of 2 years of follow-up. The threshold of subsidence >3 mm was considered as a clinically significant migration.
RESULTS: A multivariate regression analysis of subsidence across Dorr type, controlling for age, gender, and intraoperative calcar fracture, demonstrated 0.40 mm (P = .28) and 0.18 mm (P = .51) greater subsidence in Dorr type C and B when compared to Dorr type A. Age, gender, and calcar fracture had no influence on subsidence, whereas greater canal-fill ratio at 2 cm below lesser trochanter resulted in significantly less subsidence (P = .02). Additionally, all variables did not affect the risk of having subsidence >3 mm.
CONCLUSION: The proximal femoral morphology has no statistically significant effect on the subsidence of fully HA-coated stem. Therefore, this stem type might be a viable option for Dorr type C. Increasing the canal-fill ratio at metadiaphyseal junction may ensure the stability of the stem.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dorr classification; cementless femoral stem; hydroxyapatite-coated; proximal femoral morphology; subsidence; total hip arthroplasty

Mesh:

Substances:

Year:  2019        PMID: 31182412     DOI: 10.1016/j.arth.2019.05.017

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  5 in total

1.  Cementless total hip arthroplasty with anatomic-shaped implants. Does the minimal invasive anterolateral technique influence the stem position or subsidence in contrast to the standard lateral approach?

Authors:  Nils Wirries; Marcus Örgel; Michael Schwarze; Stefan Budde; Henning Windhagen; Michael Skutek
Journal:  Arch Orthop Trauma Surg       Date:  2021-08-14       Impact factor: 2.928

2.  Leg length measures appear inaccurate in the early phase following total hip arthroplasty.

Authors:  Maria Anna Smolle; Stefan Franz Fischerauer; Michael Maier; Patrick Reinbacher; Jörg Friesenbichler; Paul Ruckenstuhl; Maria Grandesso; Andreas Leithner; Werner Maurer-Ertl
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

3.  Survival and performance of a dual tapered-wedge fully HA-coated press fit femoral stem.

Authors:  Ramakanth R Yakkanti; Dylan N Greif; Dennis J Vanden Berge; Raymond P Robinson
Journal:  Arch Orthop Trauma Surg       Date:  2022-03-03       Impact factor: 3.067

4.  Tapered wedge stems decrease early postoperative subsidence following cementless total hip arthroplasty in Dorr type C femurs compared to fit-and-fill stems.

Authors:  Satoshi Ikemura; Goro Motomura; Satoshi Hamai; Masanori Fujii; Shinya Kawahara; Taishi Sato; Daisuke Hara; Kyohei Shiomoto; Yasuharu Nakashima
Journal:  J Orthop Surg Res       Date:  2022-04-10       Impact factor: 2.359

5.  The intraoperative use of a calliper predicts leg length and offset after total hip arthroplasty. Component subsidence influences the leg length.

Authors:  Maliha Fansur; Nagib A Yurdi; Reinhard Stoewe
Journal:  J Orthop Surg Res       Date:  2021-07-03       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.